Cargando…

Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era

OBJECTIVE: To analyze self-reported adherence to antiretroviral regimens containing ritonavir-boosted protease inhibitors, non-nucleoside reverse transcriptase inhibitors (NNRTI), raltegravir, and maraviroc. METHODS: Overall, 372 consecutive subjects attending a reference center for HIV treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sterrantino, G, Santoro, L, Trotta, M, Antinori, A, Bartolozzi, D, Zaccarelli, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2012
Materias:	Poster Abstract – P19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512501/ http://dx.doi.org/10.7448/IAS.15.6.18104

Ejemplares similares

Self-reported adherence supports patient preference for the single tablet regimen (STR) in the current cART era
por: Sterrantino, Gaetana, et al.
Publicado: (2012)

Who gets single tablet regimens (STR), and why?
por: Tarrier, Laura, et al.
Publicado: (2014)

Adherence in HIV-positive patients treated with single-tablet regimens and multi-pill regimens: findings from the COMPACT study
por: Antinori, A, et al.
Publicado: (2012)

Among once-daily regimens, single tablet regimens (STRs) are associated with better adherence
por: Murri, R, et al.
Publicado: (2012)

Darunavir-based dual therapy in HIV experienced patients
por: Sterrantino, Gaetana, et al.
Publicado: (2014)

Four-drugs regimen containing raltegravir is highly effective in HIV patients starting therapy with >500,000 copies/mL viral load
por: Sterrantino, Gaetana, et al.
Publicado: (2014)

Single-tablet regimen is associated with reduced efavirenz withdrawal in antiretroviral naïve or switching for simplification HIV-infected patients
por: Fabbiani, M, et al.
Publicado: (2012)

ACTG-HIV symptoms changes in patients switched to RPV/FTC/TDF due to previous intolerance to CART. Interim analysis of the PRO-STR study
por: Podzamczer, Daniel, et al.
Publicado: (2014)

High levels of transaminases at admission predict a severe disease course in COVID-19 hospitalized patients
por: Pelizzaro, F., et al.
Publicado: (2021)

1255. Single-tablet Regimens (STR) Offer Better Persistence and Adherence, with Lower Costs by Adherence Status, than Multiple-tablet Regimens (MTR) for People Living with HIV (PLWH) Enrolled in Medicaid
por: Brogan, Andrew P, et al.
Publicado: (2022)

No significant association between patient self-reported non-adherence to antiretrovirals and HIV-tropism: a preliminary analysis
por: Ammassari, A, et al.
Publicado: (2012)

Cohorte de suivi des patients ayant présenté une embolie pulmonaire dans le cadre d’une infection à COVID-19
por: Doutrelon, Caroline, et al.
Publicado: (2023)

Single-tablet regimens (STRs) enhance patients’ acceptability of HAART
por: Maggiolo, F, et al.
Publicado: (2012)

AIDS defining opportunistic infections in patients with high CD4 counts in the combination antiretroviral therapy (cART) era: things ain't what they used to be
por: Gisler, Valentin, et al.
Publicado: (2014)

An observational comparison of first-line combination antiretroviral treatment (cART) with 2NRTI and ATV/r or DRV/r in HIV-infected patients in Italy
por: Cozzi-Lepri, Alessandro, et al.
Publicado: (2014)

Switching from an EFV-based STR to a RPV-based STR is effective, safe and improves HIV patients health status
por: Maggiolo, Franco, et al.
Publicado: (2014)

Factors associated with HPV-DNA clearance in a cohort of HIV-positive patients: role of cART and gender
por: Suardi, Elisa, et al.
Publicado: (2014)

Benefits of ART simplification on adherence, clinical and economic outcomes
por: Vera, J, et al.
Publicado: (2012)

Disseminated toxoplasmosis in an HIV positive patient in cART era
por: Cambrea, Simona Claudia, et al.
Publicado: (2014)

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort
por: Pinnetti, Carmela, et al.
Publicado: (2014)

The importance of viral blips and duration of therapy initiated in primary infection in maintaining viral control after stopping cART
por: Fidler, Sarah, et al.
Publicado: (2014)

Effect of once-daily FDC treatment era on initiation of cART
por: Mosen, David M, et al.
Publicado: (2010)

Disruption of Timing: NeuroHIV Progression in the Post-cART Era
por: McLaurin, Kristen A., et al.
Publicado: (2019)

Bloodstream infections in patients living with HIV in the modern cART era
por: Taramasso, L., et al.
Publicado: (2019)

Randomized trial of DRV/r or LPV/r QD monotherapy vs maintaining a PI/r-based antiretroviral regimen in persons with suppressed HIV replication
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis
por: Zaccarelli, Mauro, et al.
Publicado: (2014)

Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with LPV/r+3TC for initial ART in HIV infected adults
por: Gatell, Josép M, et al.
Publicado: (2014)

Darunavir in experienced patients
por: Sterrantino, G, et al.
Publicado: (2010)

Real-world medication persistence with single versus multiple tablet regimens for HIV-1 treatment
por: Sweet, Donna, et al.
Publicado: (2014)

HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART
por: Jacobson, Caron A., et al.
Publicado: (2012)

Does a simplified regimen give a better adherence, treatment satisfaction, and quality of life?
por: Langebeek, N, et al.
Publicado: (2012)

Association between obesity and combination antiretroviral therapy (cART) adherence among persons with early-stage HIV infection initiating cART
por: Musinguzi, Nicholas, et al.
Publicado: (2021)

Expert consensus criteria and practical recommendations for pbc care in the covid-19 era and beyond
por: Berenguer, M., et al.
Publicado: (2022)

Effectiveness of antiretroviral therapy in the single-tablet regimen era
por: Costa, Juliana de Oliveira, et al.
Publicado: (2018)

Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA(®), Because of a Previous Intolerance to cART. PRO-STR Study
por: Podzamczer, D., et al.
Publicado: (2018)

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort
por: Capetti, Amedeo F., et al.
Publicado: (2016)

Effectiveness and durability of darunavir/ritonavir (DRV/r) in DRV/r-experienced HIV-1-infected patients in routine clinical practice
por: Antinori, Andrea, et al.
Publicado: (2014)

Is anemia still a problem in cART era: a single center study?
por: Genet, P, et al.
Publicado: (2014)

MR spectroscopy in HIV associated neurocognitive disorder in the era of cART: a review
por: Chaganti, Joga, et al.
Publicado: (2021)

Hepatic safety of RPV/FTC/TDF single tablet regimen in HIV/HCV-coinfected patients. Preliminary results of the hEPAtic Study
por: Neukam, Karin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_3dtmcgg9sjno3pcjhp50ojj6l1